ARCHIVES

Inhibitor Reduces Spleen Size By 35 Percent or More in Phase III

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

“National Clearinghouse” To Guide Selection, Testing, Evaluating Of Suspected Carcinogens

April 9, 1976

Heart Failure Rare Among Leukemia Patients On Imatinib

September 28, 2007

“Start Fighting” Says Former Rep. John Porter To Crowd of 12,000 at AACR Washington Rally

April 12, 2013

In congress: Scientists Seek Closing NIH Office Of Alternative Medicine

July 11, 1997

Orlando Health President Mark Rohl We Opted For A Florida-Centric Strategy

January 10, 2014

Komen Deal With KFC Yields Buckets Of Discord

April 23, 2010